Resveratrol could boost radiation therapy

Research has indicated that a compound found in red wine could make prostate tumour cells more susceptible to radiation therapy.

Red wine could help in the fight against prostate cancerWith Movember well underway there is a focus on men’s health this month and scientists hope they may have made a key breakthrough in prostate cancer treatment.

It has previously been claimed that red wine can have a positive effect on cardiovascular health and stroke prevention as well as helping decrease prostate cancer. This breakthrough shows the compound, called resveratrol, can help with the treatment of prostate cancer.

Researchers from the University of Missouri have found, for the first time, that resveratrol makes prostate tumour cells more susceptible to radiation treatment. Resveratrol is found in red wine and grapes skins.

Professor Michael Nicholl, from the University of Missouri’s School of Medicine said: “Other studies have noted that resveratrol made tumour cells more susceptible to chemotherapy, and we wanted to see if it had the same effect for radiation therapy.

“We found that when exposed to the compound, the tumour cells were more susceptible to radiation treatment, but that the effect was greater than just treating with both compounds separately.”

However, the resveratrol dosage needed to have an effect on the tumour cells is so high that most people would experience uncomfortable side effects. So scientists are looking at a more effective delivery method.

Professor Nicholl added: “We don’t need a large dose at the site of the tumour, but the body processes this compound so efficiently that a person needs to ingest a lot of resveratrol to make sure enough of it ends up at the tumour site.

“Because of that challenge, we have to look at different delivery methods for this compound to be effective.”

The next stage for the treatment is animal testing before clinical trials can begin. If the trials are successful, it could lead to a significant development in cancer treatment in the next few years.

Researcher Dr Axel Thompson said: “This is an extremely exciting development that has the potential to form the basis of a revolution in prostate cancer treatments over time if replicated in humans.

“By targeting the fibroblasts that control the growth of the cancer these new treatments could be both more effective and likely to lead to significantly fewer side effects.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note that comments are subject to our posting guidelines in accordance with the Defamation Act 2013. Posts containing swear words, discrimination, offensive language and libellous or defamatory comments will not be approved.

Subscribe to our newsletters

Fine Wine Sales Administrator

Davy's Wine Merchants
London, UK

Content Manager (Maverick Drinks)

ATOM Supplies
London, UK

Graphic Designer (NPD)

ATOM Supplies
Tunbridge Wells, UK

Press Officer

Speciality Drinks
London, UK

UK Private Clients Manager

Ditton Wine Traders
London, UK

London Business Development Manager

Maisons Marques et Domaines UK Ltd

Head of Buying - Spirits

Enotria&Coe
West London, UK

Liquid Production Supervisor

ATOM Supplies
Tonbridge, Kent, UK

Sales Account Manager – Cotswolds

Haynes Hanson & Clark
Gloucestershire, UK

Communications & PR Manager

Bruichladdich
Islay, UK

International Bulk Wine and Spirits Show

London,United Kingdom
26th Feb 2018

Spirited London

London,United Kingdom
15th Mar 2018

Prowein 2018

Dusseldorf,Germany
18th Mar 2018
Click to view more

The Global Malbec Masters 2017

the drinks business is proud to announce the inaugural Global Malbec Masters 2017

The Global Sparkling Masters 2017

the drinks business is thrilled to announce the launch of The Global Sparkling Masters.

Click to view more